Revena raises $8M seed
Revena raised $8M in seed funding, announced on 1 January 2026, led by Canary, with participation from Flourish Ventures, Caravela Capital. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
Healthtech company that develops AI agents to generate medical bills from clinical records and payer rules. Revena is based in Brazil and currently at seed stage, operating in healthtech, AI, SaaS.
This funding event is a citable node in Fusion42's market graph: it links Revena's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur, Fusion42's AI co-founder, reasons over when benchmarking a founder's own raise against what is closing in the market right now.
Round details
| Company | Revena |
| Stage | seed |
| Amount | $8M |
| Announced | 1 January 2026 |
| Lead | Canary |
| Participation | Flourish Ventures, Caravela Capital |
| Source | announcement ↗ |
Frequently asked questions
- How much did Revena raise?
- Revena raised $8M in its seed round, announced 2026-01-01.
- Who invested in Revena's seed round?
- The round was led by Canary, with participation from Flourish Ventures and Caravela Capital.
- What does Revena do?
- Healthtech company that develops AI agents to generate medical bills from clinical records and payer rules.
Verified 2 May 2026 · Sources: public filings